You are here: Industry Insights > cancer

News List

Fragmentation Profiles of Cell-Free DNA Can Detect Cancer drugs
June 06, 2019
Fragmentation Profiles of Cell-Free DNA Can Detect Cancer.
Lynparza reduces PFS in germline BRCA-mutated pancreatic cancer pharmaceutical-technology
June 05, 2019
AstraZeneca and Merck have announced that Lynparza (olaparib) demonstrated significant improvement in progression-free survival (PFS), compared to placebo, in germline BRCA-mutated metastatic .adenocarcinoma of the pancreas.
Pembrolizumab trumps chemotherapy in recurrent head and neck cancer pharmaceutical-technology
June 05, 2019
Research has shown that immunotherapy pembrolizumab alone and in combination with chemotherapy is a more efficacious first line treatment for head and neck cancer that has returned than aggressive chemotherapy.
Health Tip: Understanding Liver Spots drugs
June 05, 2019
Understanding Liver Spots.
Is MRI Screening Worth It for Breast Cancer Survivors? drugs
June 05, 2019
Breast MRI screening is a good way to detect small tumors, but it's unclear how much it benefits women with a history of breast cancer, a new study finds.
Testicular Cancer Treatment Unlikely to Trigger Birth Defects drugs
June 05, 2019
Testicular Cancer Treatment Unlikely to Trigger Birth Defects.
ASCO: Olaparib Beats Placebo for BRCA-Related Pancreatic Cancer drugs
June 05, 2019
Olaparib Beats Placebo for BRCA-Related Pancreatic Cancer.
ASCO: Survival Up With Ribociclib in Advanced Breast Cancer drugs
June 05, 2019
Survival Up With Ribociclib in Advanced Breast Cancer.
Higher Surgical Volume May Improve Outcomes in Cervical Cancer drugs
June 04, 2019
Higher Surgical Volume May Improve Outcomes in Cervical Cancer.
ASCO: Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer drugs
June 04, 2019
Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer.